HRP960341A2 - New methods of using n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) - Google Patents

New methods of using n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) Download PDF

Info

Publication number
HRP960341A2
HRP960341A2 HR60/003,031A HRP960341A HRP960341A2 HR P960341 A2 HRP960341 A2 HR P960341A2 HR P960341 A HRP960341 A HR P960341A HR P960341 A2 HRP960341 A2 HR P960341A2
Authority
HR
Croatia
Prior art keywords
methylethyl
bis
phenyl
sulfamic acid
phenyl ester
Prior art date
Application number
HR60/003,031A
Other languages
English (en)
Croatian (hr)
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HRP960341A2 publication Critical patent/HRP960341A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR60/003,031A 1995-08-04 1996-07-16 New methods of using n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) HRP960341A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04

Publications (1)

Publication Number Publication Date
HRP960341A2 true HRP960341A2 (en) 1998-02-28

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
HR60/003,031A HRP960341A2 (en) 1995-08-04 1996-07-16 New methods of using n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters)

Country Status (27)

Country Link
US (1) US6117909A (de)
EP (1) EP0841913B1 (de)
JP (1) JPH11510184A (de)
KR (1) KR19990036127A (de)
CN (1) CN1192140A (de)
AT (1) ATE232097T1 (de)
AU (1) AU716255B2 (de)
BG (1) BG63863B1 (de)
CA (1) CA2221729A1 (de)
CZ (1) CZ26198A3 (de)
DE (1) DE69626118T2 (de)
DK (1) DK0841913T3 (de)
EA (1) EA002435B1 (de)
EE (1) EE9800037A (de)
ES (1) ES2191762T3 (de)
GE (1) GEP20012511B (de)
HR (1) HRP960341A2 (de)
HU (1) HUP9900668A3 (de)
IL (1) IL122247A0 (de)
NO (1) NO980466L (de)
NZ (1) NZ312571A (de)
PL (1) PL185943B1 (de)
PT (1) PT841913E (de)
SK (1) SK12598A3 (de)
UA (1) UA46030C2 (de)
WO (1) WO1997005868A1 (de)
ZA (1) ZA966617B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (de) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Verwendung von Acetylcoenzyme A Inhibitoren zur Behandlung von Alzheimer
CN1310629A (zh) * 1998-07-21 2001-08-29 沃尼尔·朗伯公司 用于治疗动脉粥样硬化损伤的acat和mmp抑制剂的合并给药
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
HUP0203160A3 (en) * 1999-11-05 2006-02-28 Warner Lambert Co Prevention of plaque rupture by acat inhibitors
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
KR102718287B1 (ko) 2017-11-14 2024-10-16 머크 샤프 앤드 돔 엘엘씨 인돌아민 2,3-디옥시게나제 (ido) 억제제로서의 신규 치환된 비아릴 화합물
WO2019099294A1 (en) 2017-11-14 2019-05-23 Merck Sharp & Dohme Corp. Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
ES2067254T3 (es) * 1990-10-30 1995-03-16 Warner Lambert Co Oxisulfonilcarbamatos.
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
HUP9900668A2 (hu) 1999-06-28
PL324908A1 (en) 1998-06-22
CA2221729A1 (en) 1997-02-20
UA46030C2 (uk) 2002-05-15
DE69626118T2 (de) 2003-11-27
CN1192140A (zh) 1998-09-02
KR19990036127A (ko) 1999-05-25
NO980466D0 (no) 1998-02-03
BG63863B1 (bg) 2003-04-30
ES2191762T3 (es) 2003-09-16
WO1997005868A1 (en) 1997-02-20
EA002435B1 (ru) 2002-04-25
NO980466L (no) 1998-02-03
ATE232097T1 (de) 2003-02-15
US6117909A (en) 2000-09-12
IL122247A0 (en) 1998-04-05
EP0841913A1 (de) 1998-05-20
HUP9900668A3 (en) 2000-08-28
EE9800037A (et) 1998-08-17
AU6454196A (en) 1997-03-05
GEP20012511B (en) 2001-08-27
EA199800176A1 (ru) 1998-10-29
PL185943B1 (pl) 2003-09-30
EP0841913B1 (de) 2003-02-05
CZ26198A3 (cs) 1998-07-15
ZA966617B (en) 1997-02-18
BG102222A (en) 1998-09-30
SK12598A3 (en) 1999-02-11
NZ312571A (en) 2000-07-28
PT841913E (pt) 2003-06-30
AU716255B2 (en) 2000-02-24
DE69626118D1 (de) 2003-03-13
DK0841913T3 (da) 2003-05-05
JPH11510184A (ja) 1999-09-07

Similar Documents

Publication Publication Date Title
RU2239456C2 (ru) Применение ингибиторов 3-гидрокси-3-метилглутарил-кофермент а-редуктазы в производстве лекарственного средства для лечения диабетической невропатии
CA2323839C (en) Treatment of neuropathy
KR100449604B1 (ko) 지질농도를 조절하는 제약 조성물 및 방법
US8048873B2 (en) Synergistic pharmaceutical combination for the prevention or treatment of diabetes
ES2334672T3 (es) Composicion farmaceutica que comprende un combinacion de metformina y una estatina.
CA2386990A1 (en) Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
HRP960341A2 (en) New methods of using n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters)
AU661748B2 (en) Use of renin inhibitors for the treatment of glaucoma
RU2151597C1 (ru) Способ ингибирования пролиферации кератиноцитов
US5846977A (en) Nerve growth factor production accelerators and compositions for preventing or treating neuronal degeneration
JP2001527551A (ja) Ｍｔｐインヒビターと脂溶性ビタミンの組合せおよび該組合せを用いる血清脂質レベルの降下法
WO1999043308A2 (en) Treating pulmonary hypertension through tenascin suppression and elastase inhibition
MXPA97009275A (en) Use of derivatives of sulfamic acid, acil sulfonamides or sulfonil carbamates for the manufacture of a medicinal product to reduce delipoprotei levels
WO2006083214A1 (en) Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor
JP2008528704A (ja) 心臓血管系疾患の治療または予防において使用するためのニトロキシド類
JP2010520854A (ja) 高コレステロール血症の治療又は予防において使用するためのニトロキシド
AU2002301821B2 (en) Treatment of Neuropathy
HK1015278A (en) Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
Murakami et al. Hipolipidemic effects of HL-004, a novel ACAT inhibitor, in hamsters fed normal chow
Muls et al. Sequential fibrate and low-dose simvastatin treatment in 6422 patients with severe hypercholesterolemia: The Belgian General Practitioner's Study

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected